Purpura fulminans caused by meningococcemia
- OUTBREAK NEWS. // Weekly Epidemiological Record;8/25/2000, Vol. 75 Issue 34, p273
Reports the outbreak of meningococcal diseases in Ethiopia. Total number of cases and death; Detection of Neisseria meningitidis serogroups A by latex agglutination tests; Determination of age group affected by the disease.
- Meningitis Dipstick Rapid Test: Evaluating Diagnostic Performance during an Urban Neisseria meningitidis Serogroup A Outbreak, Burkina Faso, 2007. Rose, Angela M. C.; Mueller, Judith E.; Gerstl, Sibylle; Berthe-Marie Njanpop-Lafourcade; Page, Anne-Laure; Nicolas, Pierre; Traoré, Ramata Ouédraogo; Caugant, Dominique A.; Guerin, Philippe J. // PLoS ONE;2010, Vol. 5 Issue 6, p1
Meningococcal meningitis outbreaks occur every year during the dry season in the ''meningitis belt'' of sub-Saharan Africa. Identification of the causative strain is crucial before launching mass vaccination campaigns, to assure use of the correct vaccine. Rapid agglutination (latex) tests are...
- Serogrouping of non-interpretable Neisseria meningitidis carriage strains, using rapid diagnostic tests. Hamidou, Amina Amadou; Djibo, Saacou; Mamane, Ali Elhadj; Moussa, Amadou; Chanteau, Suzanne // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jan2008, Vol. 102 Issue 1, p99
Summary: Large-scale Neisseria meningitidis (Nm) carriage studies in Africa are hampered by the lack of easy-to-perform and reliable methods for serogrouping strains that are largely polyagglutinable or autoagglutinable isolates using the conventional agglutination method. We tested the recently...
- MCV4. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1416
A definition of the acronym MCV4 which means meningococcal conjugate vaccine is presented.
- Reviewing the Use of Meningococcal Vaccine. Sadovsky, Richard // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1256
Presents an abstract of the study `Update on Meningococcal Vaccine,' by G. Peter, from the March 2001 issue of `Pediatric Infectious Disease Journal.'
- Meningitis stockpile for Africa. // Weekly Epidemiological Record;12/13/2002, Vol. 77 Issue 50, p430
Focuses on the outbreak of meningococcal disease in Africa. Funds needed to build a stockpile of vaccine and drugs.
- How to Vaccinate 30,000 People in Three Days: Realities of Outbreak Management. Osterholm, Michael T. // Public Health Reports;Sep2001 Supplement 2, Vol. 116 Issue 5, p74
Focuses on an outbreak of Neisseria meningitidis serogroup C in Mankato, Minnesota in 1995. Details of the outbreak; Issues confronting the community response to an outbreak; Issues related to vaccine administration.
- Meningococcal Vaccines: A Progress Report. Wildes, S.S.; Tunkel, A.R. // BioDrugs;2002, Vol. 16 Issue 5, p321
Neisseria meningitidis causes a wide range of human disease and remains a common cause of septicaemia and meningitis. Meningococcal serogroups A, B, C and Y cause the majority of cases of invasive disease in the US and throughout the world, with epidemics usually caused by serogroups A and C....
- Another vaccine for meningococcal disease may be moving toward licensure. Blazek, Nicole; Volansky, Rob; Zacharyczuk, Colleen // Infectious Diseases in Children;Oct2009, Vol. 22 Issue 10, p18
The article discusses research on an investigational vaccine for meningococcal disease, by Jackson and colleagues, published in the 2009 issue of "Clinical Infectious Diseases."